HEALTH
The Need to Expand What We Mean by Value in Cancer Trials
Fri May 30 2025
Cancer trials typically focus on how well a treatment works and how safe it is. But there's more to consider. Patients also deal with how treatment affects their daily lives, their finances, and the time it takes. These factors are just as important. They can greatly influence a patient's experience and overall well-being.
A new idea is to look at cancer trials in a more rounded way. This means including not just how well a treatment works, but also how it affects patients' lives and how much it costs. This approach could help doctors and patients make better choices together. It could also make cancer care more fair and effective.
One way to do this is by using a special chart, like a radar chart. This chart can show different aspects of a treatment all at once. It can help patients and doctors see the big picture. But this isn't easy. It requires more work and can be complex. Plus, everyone needs to agree on what's important. This includes doctors, patients, and even insurance companies.
The goal is to make this kind of assessment standard in cancer research. This could lead to better care for patients. It could also help ensure that treatments are not only effective but also practical and affordable. But to get there, everyone involved needs to work together. They need to find a way to measure value that works for everyone.
Cancer research is always changing. New treatments and technologies are always on the horizon. But to make the most of these advances, it's important to consider all aspects of value. This means looking beyond just how well a treatment works. It means considering how it affects patients' lives and how much it costs. Only then can cancer care truly be patient-centered.
continue reading...
questions
Are the proposed changes in value assessment part of a larger agenda to control and monetize patient data?
Will the new radar chart for value-based decisions include a 'patient happiness' meter that goes from 'cancer who?' to 'bring on the chemo'?
How can the inclusion of cost-effectiveness analyses in cancer trials be standardized to ensure fairness and transparency?
inspired by
actions
flag content